ReviewAdvances in therapy2019

Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine.

Yehuda Handelsman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.